Kirsch 2022 Minimally Invasive Sustainedrelease Relaxin

··2022·

Quick Facts

Study Type

Not classified

Evidence

Not graded

Sample

Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:: Kirsch 2022 Minimally Invasive Sustainedrelease Relaxin
Published In:: (2022)
Authors:
Database ID:: RPEP-05950

Evidence Hierarchy

Meta-Analysis / Systematic Review

Randomized Controlled Trial

Cohort / Case-Control

Cross-Sectional / ObservationalSnapshot without intervening

This study

Case Report / Animal Study

What do these levels mean? →

Cite This Study

RPEP-05950·https://rethinkpeptides.com/research/RPEP-05950

APA

. (2022). Kirsch 2022 Minimally Invasive Sustainedrelease Relaxin. .

MLA

. "Kirsch 2022 Minimally Invasive Sustainedrelease Relaxin." , 2022.

RethinkPeptides

RethinkPeptides Research Database. "Kirsch 2022 Minimally Invasive Sustainedrelease Relaxin" RPEP-05950. Retrieved from https://rethinkpeptides.com/research/kirsch-2022-minimally-invasive-sustainedrelease-relaxin

Access the Original Study

Search PubMed

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.

← Back to Research Database